Morrison J C, Blake P G, McCoy C, Martin J N, Wiser W L
Obstet Gynecol. 1983 Jan;61(1):22-4.
The contraction stress test (CST) and nonstress test (NST) are used as fetal health assessments. Severe sickle hemoglobinopathies in the parturient have been shown to place the fetus significantly at risk. This study correlates these fetal health assessment tests with outcome data in 58 pregnancies occurring in women with sickle cell disease. There were 30 patients with homozygous sickle cell anemia (HbS-S), 19 with hemoglobin S-C disease (HbS-C), and nine with hemoglobin S-thalassemia (HbS-Thal). All received prophylactic partial exchange transfusions as part of their antepartal care. At 34 weeks' gestation, NSTs followed by CSTs were begun in each patient. A total of 255 tests were performed. Of these, 19 NSTs and 24 CSTs were unsatisfactory or questionably abnormal and were repeated. There were no nonreactive NSTs, and no patient demonstrated a positive CST. The neonatal outcome revealed one infant who was small for gestational age and two infants who were of low birth weight but appropriate for gestational age. All infants survived and were normal. These data suggest that the fetal reactivity and placental reserve among these parturients with severe sickle hemoglobinopathies were uncompromised, as these tests have been shown to be relatively sensitive assessments of fetal well-being in other maternal disorders.
宫缩应激试验(CST)和无应激试验(NST)被用作胎儿健康评估方法。已表明,产妇患有严重镰状血红蛋白病会使胎儿面临显著风险。本研究将这些胎儿健康评估测试与58例镰状细胞病女性怀孕的结局数据相关联。其中有30例纯合子镰状细胞贫血(HbS-S)患者,19例血红蛋白S-C病(HbS-C)患者和9例血红蛋白S-地中海贫血(HbS-Thal)患者。作为产前护理的一部分,所有患者均接受了预防性部分换血治疗。妊娠34周时,对每位患者开始进行NST,随后进行CST。总共进行了255次测试。其中,19次NST和24次CST结果不满意或可疑异常,因此进行了重复测试。没有NST无反应的情况,也没有患者CST呈阳性。新生儿结局显示,有1例婴儿小于胎龄,2例婴儿出生体重低但与胎龄相符。所有婴儿均存活且正常。这些数据表明,这些患有严重镰状血红蛋白病的产妇的胎儿反应性和胎盘储备并未受到损害,因为这些测试已被证明是对其他母体疾病中胎儿健康状况相对敏感的评估方法。